Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Leukemia in pregnancy.

J Brell1, M Kalaycio

  • 1The Moll Cancer Center, Fairview General Hospital, Cleveland, OH, USA.

Seminars in Oncology
|December 29, 2000
PubMed
Summary

Managing leukemia during pregnancy requires careful consideration of treatment timing. While cytotoxic chemotherapy is generally avoided in the first trimester due to malformation risks, it

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influence of pre-transplant estimated glomerular filtration rate (eGFR) on clinical outcomes after allogeneic hematopoietic cell transplantation.

Bone marrow transplantation·2025
Same author

Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodine.

Leukemia·2017
Same author

Impact of cigarette smoking on survival after myeloablative allogeneic hematopoietic stem cell transplantation and contribution of invasive fungal infection.

Bone marrow transplantation·2017
Same author

The complexity of interpreting genomic data in patients with acute myeloid leukemia.

Blood cancer journal·2016
Same author

The relationship between eligibility criteria and adverse events in randomized controlled trials of hematologic malignancies.

Leukemia·2016
Same author

GvHD-free, relapse-free survival after reduced-intensity allogeneic hematopoietic cell transplantation in older patients with myeloid malignancies.

Bone marrow transplantation·2016

Area of Science:

  • Obstetrics and Gynecology
  • Hematology
  • Perinatology

Background:

  • Limited validated data exists on leukemia management during pregnancy.
  • Pregnancy presents unique challenges for treating hematologic malignancies.
  • Fetal malformation risks are a key concern, especially with folate antagonists in the first trimester.

Purpose of the Study:

  • To summarize current understanding of leukemia treatment in pregnant patients.
  • To provide guidance on managing acute and chronic leukemias during gestation.
  • To assess the impact of leukemia treatment on fetal development.

Main Methods:

  • Review of existing literature and clinical data on leukemia in pregnancy.
  • Analysis of treatment protocols and outcomes.
  • Evaluation of fetal and long-term child development data.

Main Results:

  • Cytotoxic agents generally avoided in the first trimester (approx. 17% fetal malformation risk).
  • Prompt chemotherapy indicated for acute leukemias to ensure maternal survival.
  • Treatment post-first trimester is generally safe with monitoring.
  • Chronic leukemias can often be managed post-delivery.
  • Leukemia treatment during pregnancy shows no significant impact on child's future growth and development.

Conclusions:

  • Leukemia treatment during pregnancy is feasible with tailored approaches.
  • Risk-benefit analysis is crucial for first-trimester treatment decisions.
  • Maternal survival and fetal well-being can be balanced with appropriate obstetric and hematologic care.

Related Experiment Videos